From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL Management. Martino EA, Caserta S, Vigna E, Bruzzese A, et al. Eur J Haematol 2026;117:305-319.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Martino EA, Caserta S, Vigna E, Bruzzese A, et al. From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL Management. Eur J Haematol 2026;117:305-319.
PMID: 42003055